Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Specific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01594424
What this trial is testing

A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation

Who this might be right for
End Stage Renal Disease (ESRD)
Cedars-Sinai Medical Center 10
Not applicableStudy completedNCT04897438
What this trial is testing

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

Who this might be right for
Kidney Transplant RejectionAntibody-mediated RejectionKidney Transplant Failure
Charite University, Berlin, Germany 40
Post-approval studies (Phase 4)Study completedNCT02078193
What this trial is testing

Efficacy of Belatacept in Reducing DSA

Who this might be right for
Kidney Transplantation
East Carolina University 3
Not applicableStudy completedNCT03423901
What this trial is testing

Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation

Who this might be right for
Kidney Transplant
University Hospital, Toulouse 58
Large-scale testing (Phase 3)Looking for participantsNCT04877288
What this trial is testing

Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Who this might be right for
Renal Allograft Recipients
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Not applicableUnknownNCT03702257
What this trial is testing

DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection

Who this might be right for
Lung Transplant RecipientDonor Specific AntibodiesAntibody Mediated Rejection
University Hospital, Strasbourg, France 80
Not applicableUnknownNCT03714113
What this trial is testing

Donor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Medical University of Warsaw 100
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Large-scale testing (Phase 3)Looking for participantsNCT05385432
What this trial is testing

Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

Who this might be right for
Renal Transplant RejectionInduction Therapy
University Hospital, Tours 244
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableNot Yet RecruitingNCT07718308
What this trial is testing

CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAntibody-mediated Rejection
wujianyong 20
Not applicableUnknownNCT06177561
What this trial is testing

Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT

Who this might be right for
Leukemia
Ruijin Hospital 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290
Post-approval studies (Phase 4)Study completedNCT02284464
What this trial is testing

Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients

Who this might be right for
Other Complication of Kidney TransplantRenal Transplant Rejection
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 230
Large-scale testing (Phase 3)Study completedNCT02374736
What this trial is testing

Effect of Privigen Against Graft Loss

Who this might be right for
Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 18
Testing effectiveness (Phase 2)Study completedNCT03388008
What this trial is testing

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

Who this might be right for
Lung Transplant RejectionAntibody-mediated Rejection
Washington University School of Medicine 27
Early research (Phase 1)Ended earlyNCT01848301
What this trial is testing

Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation

Who this might be right for
Cardiac Allograft VasculopathyAntibody Mediated Rejection
Gladwin, Mark, MD 12
Testing effectiveness (Phase 2)Ended earlyNCT03591380
What this trial is testing

CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Wisconsin, Madison 3
Early research (Phase 1)Looking for participantsNCT06948097
What this trial is testing

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Who this might be right for
Lung Transplantation
National Heart, Lung, and Blood Institute (NHLBI) 30
Next Page